Beta-alanine: does the 'anti-acidosis' supplement work, and who actually needs it
Fresh 2026 meta-analyses show that beta-alanine's effect is narrow and not guaranteed. We break down where it can genuinely help, where it's useless, and how it differs from 'soda' (bicarbonate).
Many people first learn about beta-alanine not from an article but from a sensation: they take a pre-workout β and their skin starts to tingle, as if goosebumps are running across it. From this comes a tempting conclusion: "I feel it, so it works." In reality there's no link between the tingling and your result, and beta-alanine itself acts nothing like caffeine or bicarbonate. Let's figure out what the fresh 2026 meta-analyses say about it and who it might actually be useful for.
How it works
Beta-alanine doesn't "switch on" during a workout on its own. It's a building block: once inside the muscle, it combines with histidine to form carnosine β an intracellular buffer for hydrogen ions. When you work at high intensity, the products of anaerobic glycolysis accumulate in the muscles, acidity rises, and this is one of the reasons your legs "clog up" and your pace drops. More carnosine means a greater capacity to dampen acidosis from inside the cell.
The key difference from bicarbonate ("soda") and caffeine is in the logic of use. Bicarbonate is an extracellular buffer, taken as a single dose before the start. Caffeine also acts acutely. But carnosine builds up over weeks: it's a loading course, not a one-off dose. Taking beta-alanine an hour before a race is pointless β the effect, if it appears at all, comes only from the carnosine level that has grown over weeks.
What the 2026 meta-analyses show
Two fresh systematic reviews in Frontiers in Nutrition cool the enthusiasm.
The first (312 women, 11 randomized studies) found only one statistically significant shift β in time to exhaustion: SMD 0.49 (95% CI 0.20β0.79). That's a modest effect in the supplement's favor. But on the other measures the confidence intervals are wide and cross zero: peak power β SMD 0.24 (β0.18β0.67), anaerobic performance β 0.11 (β0.30β0.53), VOβmax β 0.32 (β0.06β0.71). Simply put, for these the effect is not proven. And β the most important caveat β the authors rated the certainty of evidence for all outcomes as "very low."
The second review targeted the popular scenario β repeated sprints (17 studies). Here no ergogenic effect was found at all: mean sprint performance SMD β0.018 (95% CI β0.207β0.170), essentially zero. Neither a larger dose nor a longer course helped. The authors' explanation is a "bioenergetic mismatch": short repeated sprints rely primarily on phosphocreatine stores and their resynthesis between efforts, not on buffering acidity. Beta-alanine simply has nothing to buffer there.
The conclusion from both reviews is the same: the effect is narrow and not guaranteed. It lies in the zone of high-intensity "aerobicβanaerobic" work lasting roughly 1β4 minutes with a large glycolytic contribution β not in long steady aerobic work and not in short sprints.
How to take it (if you decide to)
The protocol is fundamentally different from "soda":
- Dose: usually around 3.2β6.4 g per day (studies used doses from 1.6 to 6.4 g).
- In split doses: the daily dose is divided into several servings of 0.8β1.6 g β this means fewer side effects and steadier saturation.
- As a course: 4β12 weeks. This isn't "take it and go" but a methodical accumulation of carnosine.
The main side effect is paresthesia: those goosebumps and skin tingling 10β20 minutes after taking it. The sensation is harmless and passes on its own; to get rid of it, split the dose or take a sustained-release form. And once more: the tingling is a reaction to a single dose, not an indicator that carnosine has grown and the supplement has "worked."
Who it may potentially interest: middle-distance athletes, those who do a lot of interval work, and anyone whose outcome is decided by a 1β4 minute finishing kick. Who it's almost useless for: fans of pure long aerobic work (a marathon at an even pace) and those expecting an effect in short repeated sprints.
Limitations
It's worth keeping in mind the foundation these conclusions rest on. There are few studies (often <10 for a given outcome), the groups are small (frequently n < 20), and the authors rate the quality of the work cautiously β "some concerns" about risk of bias in nearly all of them. Hence the "very low" certainty of evidence: this means the real effect may turn out noticeably different from the averaged estimate. Beta-alanine is not a banned and generally well-tolerated supplement, but you shouldn't expect a guaranteed gain from it.
The bottom line
- Beta-alanine is not a pre-workout. It raises carnosine levels over weeks; a single dose before the start is useless.
- The only relatively reliable effect in the review on women is a modest gain in time to exhaustion (SMD 0.49); for power, anaerobic work, and VOβmax the effect is not proven.
- In repeated sprints there's no effect β there it's phosphocreatine that decides, not buffering.
- The niche is narrow: high-intensity work of ~1β4 minutes, not long aerobic work and not short sprints.
- Protocol: ~3.2β6.4 g/day in split doses, as a 4β12 week course. The goosebumps are a harmless side effect, not a sign of effect.
- Certainty of evidence is low β treat beta-alanine as a possible small addition to your result, not as a guarantee.
Sources: Gu J. et al., "Effects of beta-alanine supplementation on exercise performance and related physiological outcomes in women: a systematic review and meta-analysis", Frontiers in Nutrition, 2026. https://doi.org/10.3389/fnut.2026.1857513; Liang W. et al., "No ergogenic effect of Ξ²-alanine on repeated sprint ability: a systematic review and multilevel meta-analysis of randomized controlled trials", Frontiers in Nutrition, 2026. https://doi.org/10.3389/fnut.2026.1818755